Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
3.510
-0.150 (-4.10%)
At close: Oct 9, 2026, 4:00 PM EDT
3.410
-0.100 (-2.85%)
After-hours: Oct 9, 2026, 7:30 PM EDT
Edesa Biotech Market Cap
Edesa Biotech has a market cap or net worth of $47.43 million as of October 9, 2026. It is the 30,824th most valuable company in the world and the 4,710th biggest in the United States. Its market cap has increased by 147.75% in one year.
Market Cap
47.43M
Enterprise Value
37.09M
1-Year Change
147.75%
Global Rank
Country Rank
#4,710 United States
Category
ChartMarket Cap Chart
Since June 10, 2019, Edesa Biotech's market cap has increased from $37.12M to $47.43M, an increase of 27.77%. That is a compound annual growth rate of 3.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 47.43M | 300.76% |
| Dec 31, 2025 | 11.83M | 103.14% |
| Dec 31, 2024 | 5.83M | -59.72% |
| Dec 29, 2023 | 14.46M | -65.40% |
| Dec 30, 2022 | 41.80M | -45.08% |
| Dec 31, 2021 | 76.11M | 70.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aldeyra Therapeutics | 55.50M |
| Clene | 54.21M |
| LeonaBio | 54.17M |
| ImageneBio | 52.22M |
| INmune Bio | 51.62M |
| Serina Therapeutics | 51.42M |
| eXoZymes | 51.23M |
| Dogwood Therapeutics | 50.99M |